If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
658.00    -19.00 (-2.81%)
Bid:
656.00
Ask:
660.00
Spread: 4.00 (0.61%)
Market Cap: £573.28m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Directorate Change

18 Dec 2014 07:00

RNS Number : 0413A
Victrex PLC
18 December 2014
 



 

 

 

 

 

 

18 December 2014

 

Victrex plc - Directorate change

 

Victrex appoints Andrew Dougal to the Board

 

The Board of Victrex plc, an innovative world leader in high performance polymer solutions, is pleased to announce the appointment of Andrew Dougal as a non-executive director effective from 1 March 2015.

 

Andrew will bring a wealth of experience to the Board, from a lengthy executive and non-executive career of over 35 years in industrial, manufacturing and services companies. He served as Chief Executive of Hanson plc, the international building materials group, following its demerger from Hanson, the Anglo- American conglomerate, where he was Finance Director and previously held a number of senior roles in general management and finance.

 

Andrew, aged 63, is a non-executive director and Chair of the Audit Committee at Carillion plc and Creston plc. He is also a non-executive director at Premier Farnell plc. His previous non-executive roles include BPB plc, Taylor Woodrow plc and Taylor Wimpey plc. Andrew qualified as a Chartered Accountant with Ernst & Young before spending nine years as Chief Accountant with Scottish & Universal Investments, the former industrial group, prior to joining Hanson in 1986. He is a member of the Council of the Institute of Chartered Accountants of Scotland (ICAS) and Chair of its Technical Policy Board. 

Larry Pentz, Chairman of Victrex, said: "I am delighted to welcome Andrew to the Board of Victrex. He has a long track record of success in industrial and manufacturing businesses at both executive and non-executive level. Andrew's contribution to the Board and in helping shape Victrex's future growth will be invaluable." 

 

 

 

About Victrex:

 

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

 

Enquiries:

Victrex plc:

 

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Suzana Koncarevic, General Counsel & Company Secretary +44 (0) 1253 897700

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAAAXFLNLFFF
Date   Source Headline
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update
30th Jun 20251:38 pmRNSTotal Voting Rights
30th Jun 20259:13 amRNSDirector Declaration
18th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jun 20251:56 pmRNSHolding(s) in Company
2nd Jun 202511:34 amRNSBlock listing Interim Review
2nd Jun 202510:25 amRNSHolding(s) in Company
30th May 20259:50 amRNSTotal Voting Rights
27th May 202512:40 pmRNSHolding(s) in Company
13th May 20253:30 pmRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSVictrex plc – Interim Results 2025
7th May 20257:00 amRNS‘Magma’ advances via TechnipFMC award
30th Apr 202511:00 amRNSTotal Voting Rights
31st Mar 20259:17 amRNSTotal Voting Rights
21st Mar 202510:34 amRNSDirector/PDMR Shareholding
28th Feb 20259:55 amRNSTotal Voting Rights
19th Feb 20259:00 amRNSAdditional Listing
7th Feb 20251:54 pmRNSResult of AGM
7th Feb 20257:00 amRNSAGM and Trading Update
31st Jan 20259:17 amRNSTotal Voting Rights
21st Jan 20251:56 pmRNSHolding(s) in Company
6th Jan 20251:00 pmRNSAnnual Financial Report
31st Dec 20249:00 amRNSTotal Voting Rights
16th Dec 20248:52 amRNSDirector/PDMR Shareholding
11th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 202411:46 amRNSDirector/PDMR Shareholding
10th Dec 20249:28 amRNSHolding(s) in Company
3rd Dec 202410:58 amRNSDirector/PDMR Shareholding
3rd Dec 20247:00 amRNSVictrex plc - Preliminary Results 2024
2nd Dec 20249:38 amRNSBlock listing Interim Review
29th Nov 20249:07 amRNSTotal Voting Rights
14th Nov 20249:31 amRNSHolding(s) in Company
31st Oct 202412:25 pmRNSTotal Voting Rights
14th Oct 20243:09 pmRNSHolding(s) in Company
30th Sep 20241:44 pmRNSTotal Voting Rights
27th Sep 20249:22 amRNSHolding(s) in Company
24th Sep 202411:24 amRNSDirector/PDMR Shareholding
17th Sep 20242:00 pmRNSUS FDA approval: Total Knee Study
12th Sep 202411:18 amRNSDirector/PDMR Shareholding
3rd Sep 20244:20 pmRNSHolding(s) in Company
30th Aug 20243:44 pmRNSDirector/PDMR Shareholding
30th Aug 20249:16 amRNSTotal Voting Rights
23rd Aug 20243:18 pmRNSHolding(s) in Company
9th Aug 202410:08 amRNSHolding(s) in Company
5th Aug 20241:56 pmRNSDirector/PDMR Shareholding
2nd Aug 202411:51 amRNSDirector/PDMR Shareholding
1st Aug 20241:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.